Click to Share
 

Oncology Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12633798
By Biosceptre International Ltd
Biosceptre's appointment of a CMO marks a major milestone in progression to the clinic of its therapeutic anticancer vaccine BIL06v against the novel oncology target nfP2X7.
By EPG Health Media
Deep-dive insight and opinion articles available now on epgonline.org
By Viviphi
Viviphi and Avera Health (Sioux Falls, SD) announced today a first-of-its-kind clinical collaboration in precision medicine for oncology.
12607241
By Biosceptre International Limited
Biosceptre is pleased to announce the appointment of its independent Director Sir Gregory Winter as the Chair of the Board of Directors.
By Nemucore Medical Innovations
Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting multi-drug resistant cancers with a special emphasis on highly lethal women's cancers, announced today that.
By CancerPOP
Cutting edge DNA interpretation using a computational biology is now available as one of CancerPOP's many services for cancer patients.
12594491
By Verthermia, Inc.
Verthermia, Inc., a whole body hyperthermia medical device leader commercializing safe and effective complementary treatments for solid tumor cancer in the metastatic phase, announces that CEO Steve Scott will present at the 2016 BIO Investor Forum...
By Nemucore Medical Innovations
Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting multi-drug resistant cancers with a special emphasis on highly lethal women's cancers, announced today that.
12582725
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation continues its positive growth in Southern California with opening of cancer center located in Los Alamitos
12574337
By Biosceptre International Limited
Biosceptre announces today that Professor Francesco Di Virgilio, an international expert on the role of P2X7 in cancer, has joined the Scientific Advisory Board alongside its existing members, Sir Gregory Winter and Professor Terence Rabbitts.
12575297
By mariannearanda@theoncologyinstitute.com
The Oncology Institute of Hope and Innovation welcomes Dr. Kim to their team of specialists.
12571151
By The Oncology Institute of Hope and Innovation
CMS Oncology Care Model attracts almost twice the expected number of physician group practices
12563496
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation welcomes Dr. Marathe to their team of specialists.
12557019
By Biosceptre International Limited
Biosceptre announces today that Sir Gregory Winter, founder of Cambridge Antibody Technology, Domantis and a co-founder of Bicycle Therapeutics Limited has joined the Board as a non-executive Director.
12559657
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation continues its positive growth in Southern California with opening of cancer center located in Los Alamitos
By PharMedQuest
Kirby Eng, R.Ph, Vice President Business Development will discuss employer strategies and tactics that address the rapidly rising costs of oncology drugs during the Northeast Business Group on Health's Cancer Value Workshop on May 12th in New York, NY.
By BriaCell Therapeutics
Earlier this week, BriaCell Therapeutics Corp (BCT.V) (BCTXF) announced it is planning to initiate a Phase 1/2 study with BriaVax™ in the second quarter 2016.
By PharMedQuest
Kirby Eng, PharMedQuest's Vice President of Business Development, presented the topic of "Oncology Physician Drug Reimbursement" at a recent CBI Conference.
12543423
By GATC Biotech AG
GATC Biotech takes also the lead in terms of costs of liquid biopsy testing GATCLIQUID services support early implementation of such assays by providing easy technology accessibility to researchers in clinical and translational medicine
12536387
By The Oncology Institute of Hope and Innovation
Merrill Shum, MD has been named by Southern California Super Doctors® Rising Stars2016 as one of the top doctors in Lynwood, CA for 2016.

All Press Releases

12633798
By Biosceptre International Ltd
Biosceptre's appointment of a CMO marks a major milestone in progression to the clinic of its therapeutic anticancer vaccine BIL06v against the novel oncology target nfP2X7.
By EPG Health Media
Deep-dive insight and opinion articles available now on epgonline.org
By Fujifilm Sonosite
Ultrasound guidance is now routinely used for pleural procedures, with current British Thoracic Society guidelines stating that all pleural drain insertions and aspirations should be performed using the technique.
By Viviphi
Viviphi and Avera Health (Sioux Falls, SD) announced today a first-of-its-kind clinical collaboration in precision medicine for oncology.
12607241
By Biosceptre International Limited
Biosceptre is pleased to announce the appointment of its independent Director Sir Gregory Winter as the Chair of the Board of Directors.
By Nemucore Medical Innovations
Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting multi-drug resistant cancers with a special emphasis on highly lethal women's cancers, announced today that.
By CancerPOP
Cutting edge DNA interpretation using a computational biology is now available as one of CancerPOP's many services for cancer patients.
12594491
By Verthermia, Inc.
Verthermia, Inc., a whole body hyperthermia medical device leader commercializing safe and effective complementary treatments for solid tumor cancer in the metastatic phase, announces that CEO Steve Scott will present at the 2016 BIO Investor Forum...
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation welcomes Dr. Janoski to their team of specialists
By EPG Health Media
A new clinical resource has launched on epgonline.org this week. The Breast Cancer Knowledge Centre is intended for oncologists and other healthcare professionals involved in the treatment and care of patients with this condition.
By Nemucore Medical Innovations
Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting multi-drug resistant cancers with a special emphasis on highly lethal women's cancers, announced today that.
12582725
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation continues its positive growth in Southern California with opening of cancer center located in Los Alamitos
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation welcomes Dr. Kamila Bakirhan to their team of specialists
12574337
By Biosceptre International Limited
Biosceptre announces today that Professor Francesco Di Virgilio, an international expert on the role of P2X7 in cancer, has joined the Scientific Advisory Board alongside its existing members, Sir Gregory Winter and Professor Terence Rabbitts.
12575297
By mariannearanda@theoncologyinstitute.com
The Oncology Institute of Hope and Innovation welcomes Dr. Kim to their team of specialists.
By LeanTaaS
iQueue for Infusion Centers now manages 1,000+ infusion chairs across more than 35 leading cancer centers in the nation.
By Belia
Belia also offers a variety of services for personal skincare such as eyelash extensions, a variety of facials (starting at $30 for 30 minutes), brow and lash tinting, waxing, microdermabrasion and spray tanning.
12571151
By The Oncology Institute of Hope and Innovation
CMS Oncology Care Model attracts almost twice the expected number of physician group practices
12563496
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation welcomes Dr. Marathe to their team of specialists.
12557019
By Biosceptre International Limited
Biosceptre announces today that Sir Gregory Winter, founder of Cambridge Antibody Technology, Domantis and a co-founder of Bicycle Therapeutics Limited has joined the Board as a non-executive Director.
12559657
By The Oncology Institute of Hope and Innovation
The Oncology Institute of Hope and Innovation continues its positive growth in Southern California with opening of cancer center located in Los Alamitos
By PharMedQuest
Kirby Eng, R.Ph, Vice President Business Development will discuss employer strategies and tactics that address the rapidly rising costs of oncology drugs during the Northeast Business Group on Health's Cancer Value Workshop on May 12th in New York, NY.
By BriaCell Therapeutics
Earlier this week, BriaCell Therapeutics Corp (BCT.V) (BCTXF) announced it is planning to initiate a Phase 1/2 study with BriaVax™ in the second quarter 2016.
By PharMedQuest
Kirby Eng, PharMedQuest's Vice President of Business Development, presented the topic of "Oncology Physician Drug Reimbursement" at a recent CBI Conference.
12543423
By GATC Biotech AG
GATC Biotech takes also the lead in terms of costs of liquid biopsy testing GATCLIQUID services support early implementation of such assays by providing easy technology accessibility to researchers in clinical and translational medicine
12536387
By The Oncology Institute of Hope and Innovation
Merrill Shum, MD has been named by Southern California Super Doctors® Rising Stars2016 as one of the top doctors in Lynwood, CA for 2016.
By SMi Group
SMi reports (17.02.2016, London UK) ADCETRIS Global Medical Lead joins expert speaker panel at the 5th annual ADC Summit in London
12533596
By The Oncology Institute of Hope and Innovation
Richy Agajanian, M.D. Named for 2016 California SuperDoctors®
By SMi Group
SMi reports (09.02.2016, London UK): Specialists from Novartis to speak on ADC development at the 5th ADC Summit in London.
By epgonline.org
A new online CME module is now available in the Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre on epgonline.org.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share